直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
Sajeth Dinakaran, Ph.D.
Technical Specialist
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 6014
sajeth.dinakaran@finnegan.com sajeth.dinakaran@finnegan.com

Sajeth Dinakaran, Ph.D.

Technical Specialist

  • +1 202 408 6014 +1 202 408 6014
  • sajeth.dinakaran@finnegan.com sajeth.dinakaran@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard

Sajeth Dinakaran, Ph.D., applies his extensive knowledge in molecular biology and translational medicine to intellectual property (IP) matters in the biological and pharmaceutical fields. He focuses on patent prosecution and strategic counseling related to U.S. and international patent portfolios pertaining to a wide variety of technologies within the life sciences sector.

Sajeth has experience in developing global prosecution strategies. He assists in drafting and prosecuting patent applications in multiple areas in the life sciences, including antibodies, dietary supplements, fusion protein therapies, gene editing technologies, gene therapy, immuno-oncology, modified polynucleotides, fusion protein therapies, and small molecules.

 

With a doctorate in the molecular basis of medicine, Sajeth’s technical expertise includes areas such as vascular pathology, neurodegenerative disorders, and drug screening for development of therapeutics. His dissertation focused on exploring the role of cell cycle regulation in hereditary hemorrhagic telangiectasia.

 

Et Cetera

  • Author, “CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia,” Nature Cardiovascular Research, 2024.

  • Instructor, Department of Biology, Hofstra University, 2020-2023.

  • Recipient, scholarships from Donald and Barbara Zucker School of Medicine, 2019-2023.

 

Experience

Comprehensive patent transactions and strategic counseling for one of the largest pharmaceutical companies in the world

Finnegan is lead and preferred IP transactions counsel for one of the largest pharmaceutical companies in the world, handling more than 50 diligence projects each year, including all IP and related transactional aspects of the matters. The transactions span the full gamut of technologies from small molecule through biologics such as antibodies, oligonucleotides, and gene therapies. Finnegan also provides extensive assistance with post-deal integration procedures and subsequent global prosecution and portfolio strategy, ensuring a seamless transition of IP assets to the company and maximum value from acquired IP.

Insights

Federal Circuit IP Blog

Spotlight on Upcoming Oral Arguments – September 2023 Spotlight on Upcoming Oral Arguments – September 2023

September 5, 2023

Professional Activities

  • New York Academy of Sciences
    (2019-2023)
  • Young Investigators Society
    (2020-2023)
Admissions and Education

Education

Hofstra University, Donald and Barbara Zucker School of Medicine
Ph.D., Molecular Medicine, 2023
Virginia Polytechnic Institute & State University
B.S., Experimental Neuroscience, 2018

Languages

  • Tamil

Sajeth's Practices

Prosecution and Portfolio Management
Opinions and Counseling

Sajeth's Industries

Chemicals, Industrials, and Materials
Chemical
Life Sciences
Biologics
Biotechnology
Medical Device and Diagnostics
Pharmaceutical

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP